US Patent Issued to BIOVERATIV THERAPEUTICS on Sept. 2 for "Factor VIII polypeptide formulations" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 3 -- United States Patent no. 12,403,183, issued on Sept. 2, was assigned to BIOVERATIV THERAPEUTICS INC. (Waltham, Mass.).

"Factor VIII polypeptide formulations" was invented by Kevin Maloney (Waltham, Mass.), Daniel Gage (Waltham, Mass.) and Ahmad Abdul-Fattah (Waltham, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a formulation of a Factor VIII polypeptide, e.g., FVIII-Fc, and methods of using the same. The FVIII polypeptide can be a recombinant FVIII protein, a short-acting FVIII protein, or a long-acting FVIII protein. The pharmaceutical formulation comprising a FVIII polypeptide can be used for individual prophylaxis, weekly prophylaxis, epis...